Curis, Inc. (CRIS)
NASDAQ: CRIS · IEX Real-Time Price · USD
15.99
+0.64 (4.17%)
At close: May 1, 2024, 4:00 PM
15.60
-0.39 (-2.44%)
After-hours: May 1, 2024, 5:34 PM EDT
Curis Revenue
In the year 2023, Curis had annual revenue of $10.02M, a decrease of -1.37%. Revenue in the quarter ending December 31, 2023 was $2.70M, a -6.62% decrease year-over-year.
Revenue (ttm)
$10.02M
Revenue Growth
-1.37%
P/S Ratio
9.40
Revenue / Employee
$204,551
Employees
49
Market Cap
94.25M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 10.02M | -139.00K | -1.37% |
Dec 31, 2022 | 10.16M | -487.00K | -4.57% |
Dec 31, 2021 | 10.65M | -186.00K | -1.72% |
Dec 31, 2020 | 10.84M | 831.00K | 8.31% |
Dec 31, 2019 | 10.00M | -424.00K | -4.07% |
Dec 31, 2018 | 10.43M | 530.00K | 5.35% |
Dec 31, 2017 | 9.90M | 2.37M | 31.50% |
Dec 31, 2016 | 7.53M | -351.00K | -4.46% |
Dec 31, 2015 | 7.88M | -1.97M | -19.96% |
Dec 31, 2014 | 9.84M | -5.16M | -34.39% |
Dec 31, 2013 | 15.00M | -1.97M | -11.61% |
Dec 31, 2012 | 16.97M | 2.21M | 14.97% |
Dec 31, 2011 | 14.76M | -1.24M | -7.73% |
Dec 31, 2010 | 16.00M | 7.41M | 86.26% |
Dec 31, 2009 | 8.59M | 223.32K | 2.67% |
Dec 31, 2008 | 8.37M | -8.02M | -48.95% |
Dec 31, 2007 | 16.39M | 1.45M | 9.73% |
Dec 31, 2006 | 14.94M | 8.93M | 148.83% |
Dec 31, 2005 | 6.00M | 2.30M | 62.27% |
Dec 31, 2004 | 3.70M | -6.68M | -64.36% |
Dec 31, 2003 | 10.38M | -8.01M | -43.57% |
Dec 31, 2002 | 18.39M | 17.30M | 1,592.64% |
Dec 31, 2001 | 1.09M | 62.93K | 6.15% |
Dec 31, 2000 | 1.02M | -2.19M | -68.13% |
Dec 31, 1999 | 3.21M | -7.22M | -69.20% |
Dec 31, 1998 | 10.43M | -2.66M | -20.31% |
Dec 31, 1997 | 13.09M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Assertio Holdings | 152.07M |
Burning Rock Biotech | 75.80M |
ProPhase Labs | 44.38M |
BrainsWay | 31.79M |
Forian | 20.48M |
Atara Biotherapeutics | 8.57M |
BeyondSpring | 1.55M |
Milestone Pharmaceuticals | 1.00M |
CRIS News
- 1 day ago - Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 - PRNewsWire
- 26 days ago - Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 27 days ago - Curis to Present at Upcoming Healthcare Conferences in April - PRNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Curis, Inc. (NASDAQ: CRIS) - PRNewsWire
- 2 months ago - Curis Provides Fourth Quarter 2023 Business Update - PRNewsWire
- 3 months ago - Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 - PRNewsWire
- 5 months ago - Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study - PRNewsWire
- 5 months ago - Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference - PRNewsWire